Incyte Corporation vs Pinterest Inc — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Pinterest Inc trades at $22.65 (market cap $12.78B). The key difference: Incyte Corporation is the larger of the two by market cap, and Incyte Corporation is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| INCY | PINS | |
|---|---|---|
Market Cap | $23.11B | $12.78B |
Sector | Health | Media |
52-Week High | $118.52 | $39.17 |
52-Week Low | $67.38 | $15.42 |
Enterprise Value | $19.13B | $12.68B |
Trailing returns across standard periods
Latest headlines on both assets
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →